mhurhangee/ep-ind-claims huggingface dataset:
A vibration attenuation system for attenuating a transmission of an input signal, the system comprising: a helical spring that includes a plurality of helical coils (112, 114, 152, 154, 192, 194), a first end, and a second end, wherein said plurality of helical coils defines an inner volume of the helical spring intermediate the first and second ends; a first terminal that includes a first inner member, wherein the first terminal is coupled to the first end of the helical spring and the first inner member extends into the inner volume of the helical spring; and a first damping element positioned on the first inner member such that the first damping element is within the inner volume of the helical spring, and when the input signal is provided to the helical spring the first damping element engages at least one of the plurality of helical coils (112, 114, 152, 154, 192, 194) and attenuates the transmission of at least a portion of the input signal; wherein said plurality of coils (112, 114, 152, 154, 192, 194) includes a first helical coil and a second helical coil such that a distance between the first coil and the first end is greater than a distance between the second coil and the first end, and when the input signal is provided to the helical spring a magnitude of a first engagement force that is between the first damping element and the first coil is less than a magnitude of a second engagement force that is between the first damping element and the second coil. a helical spring that includes a plurality of helical coils (112, 114, 152, 154, 192, 194), a first end, and a second end, wherein said plurality of helical coils defines an inner volume of the helical spring intermediate the first and second ends; a first terminal that includes a first inner member, wherein the first terminal is coupled to the first end of the helical spring and the first inner member extends into the inner volume of the helical spring; and a first damping element positioned on the first inner member such that the first damping element is within the inner volume of the helical spring, and when the input signal is provided to the helical spring the first damping element engages at least one of the plurality of helical coils (112, 114, 152, 154, 192, 194) and attenuates the transmission of at least a portion of the input signal; wherein said plurality of coils (112, 114, 152, 154, 192, 194) includes a first helical coil and a second helical coil such that a distance between the first coil and the first end is greater than a distance between the second coil and the first end, and when the input signal is provided to the helical spring a magnitude of a first engagement force that is between the first damping element and the first coil is less than a magnitude of a second engagement force that is between the first damping element and the second coil.
Wind turbine with a rotor hub, to which at least one rotor blade is attached, a generator, which has an external rotor and an internal stator, and a drive shaft, which has a generator shaft section which is connected to the rotor of the generator, characterised in that the generator shaft section is mounted by means of a double-row tapered roller bearing or two single-row tapered roller bearings inside the stator of the generator and the drive shaft has a rotor shaft section, which is connected to the rotor hub and mounted by means of a second bearing on a machine carrier which is connected to the stator of the generator.
A combustion chamber for a turbomachine such as an aircraft turbojet or turbofan, the chamber comprising: - coaxial revolution walls (14,16) extending one inside the other and connected together at their upstream ends by an annular chamber end wall, the inner revolution and outer revolution walls including each primary air inlet orifices (52, 54) and dilution air inlet orifices formed by die stamping and having edges projecting into the inside of the combustion chamber, said combustion chamber being characterized in that: - it includes stress relaxation or reduction means in the edges or in the vicinity of the edges of at least some of said orifices, said stress relaxation or reduction means comprising, for each orifice, one, two, or three slots (80, 90, 100, 110) formed in the edge or around a portion of the edge of said orifice (52, 54), each slot being connected at at least one of its ends to a crack propagation stop orifice (82, 92, 102, 112), and - the slots (80, 90, 100, 110) and the stop orifices (82, 92, 102, 112) are oriented substantially parallel to microperforation formed in the chamber for its cooling. - coaxial revolution walls (14,16) extending one inside the other and connected together at their upstream ends by an annular chamber end wall, the inner revolution and outer revolution walls including each primary air inlet orifices (52, 54) and dilution air inlet orifices formed by die stamping and having edges projecting into the inside of the combustion chamber, said combustion chamber being characterized in that: - it includes stress relaxation or reduction means in the edges or in the vicinity of the edges of at least some of said orifices, said stress relaxation or reduction means comprising, for each orifice, one, two, or three slots (80, 90, 100, 110) formed in the edge or around a portion of the edge of said orifice (52, 54), each slot being connected at at least one of its ends to a crack propagation stop orifice (82, 92, 102, 112), and - the slots (80, 90, 100, 110) and the stop orifices (82, 92, 102, 112) are oriented substantially parallel to microperforation formed in the chamber for its cooling.
A process for the synthesis of a compound of formula wherein A is absent or is a 6-membered nitrogen containing heteroaryl optionally substituted with a -C 1-3 alkyl group; R a and R b are the same or different selected from -C 1-4 alkyl and -CH 2 -phenyl; or R a and R b together form a 5- to 7-membered saturated heterocyclyl attached via the nitrogen atom; comprising the steps of: • obtaining the compound of formula by reacting 5,6-dibromo-pyridin-2-yl-amine with a 1,1-dialkoxy- N,N- dialkylmethyl-amine of the formula (R z O) 2 -CHN(R a,R b), wherein R z is a -C 1-3 alkyl group; • reacting the compound of formula with a compound of formula A is absent or is a 6-membered nitrogen containing heteroaryl optionally substituted with a -C 1-3 alkyl group; R a and R b are the same or different selected from -C 1-4 alkyl and -CH 2 -phenyl; or R a and R b together form a 5- to 7-membered saturated heterocyclyl attached via the nitrogen atom; • obtaining the compound of formula by reacting 5,6-dibromo-pyridin-2-yl-amine with a 1,1-dialkoxy- N,N- dialkylmethyl-amine of the formula (R z O) 2 -CHN(R a,R b), wherein R z is a -C 1-3 alkyl group; • reacting the compound of formula with a compound of formula
A loudspeaker comprising: - a cabinet having at least one opening and a drive unit enclosure embedded in said opening, wherein the drive unit enclosure comprises · a housing having an inner profile for accommodating a chassis of a drive unit, a first end in connection with the opening and a second end opposite to the first end, and · a back plate at the second end of the housing, - at least one such drive unit, which comprises a chassis enclosing at least one driver (210, 220) and which at least one drive unit is essentially embedded in the opening, wherein the drive unit is secured to the cabinet from mounting points of the chassis by means of the drive unit enclosure, and - suspension means adapted between the mounting points of the chassis and the cabinet and to provide engagement and axial suspension between the drive unit and the cabinet, wherein the suspension means (411, 412) is further adapted to suspend the drive unit chassis elastically to the cabinet to allow suspension both forward and rearward, characterized in that the back plate is adapted to close the second end of the housing, whereby the drive unit is mounted to the cabinet via the enclosure. - a cabinet having at least one opening and a drive unit enclosure embedded in said opening, wherein the drive unit enclosure comprises · a housing having an inner profile for accommodating a chassis of a drive unit, a first end in connection with the opening and a second end opposite to the first end, and · a back plate at the second end of the housing, · a housing having an inner profile for accommodating a chassis of a drive unit, a first end in connection with the opening and a second end opposite to the first end, and · a back plate at the second end of the housing, - at least one such drive unit, which comprises a chassis enclosing at least one driver (210, 220) and which at least one drive unit is essentially embedded in the opening, wherein the drive unit is secured to the cabinet from mounting points of the chassis by means of the drive unit enclosure, and - suspension means adapted between the mounting points of the chassis and the cabinet and to provide engagement and axial suspension between the drive unit and the cabinet, wherein the suspension means (411, 412) is further adapted to suspend the drive unit chassis elastically to the cabinet to allow suspension both forward and rearward,
An inhaler adapted to supply a formulation comprisable in a container to a user, characterized in that the inhaler comprises: a processor unit adapted to read information stored in data storage means of the container, a detector adapted to detect whether the container or a compartment of the container is opened or pierced, a unit adapted to measure an electric characteristic of the container, the electric characteristic to be measured by the unit being dependent on whether the container or a respective compartment of the container is opened or pierced. a processor unit adapted to read information stored in data storage means of the container, a detector adapted to detect whether the container or a compartment of the container is opened or pierced, a unit adapted to measure an electric characteristic of the container, the electric characteristic to be measured by the unit being dependent on whether the container or a respective compartment of the container is opened or pierced.
System for treating process water from a machine for producing and/or finishing a paper, board, tissue or other fibrous web, wherein the process water is subdivided in a sorting or filtering device into a plurality of partial fractions (9, 10) having differently high proportions of fibres, characterized in that at least two partial fractions (9, 10) are led at least partly over at least one predefined time interval to a common washing device, the fine fraction from this washing device can be led to a flotation device and the accept of this flotation device can be led to the machine, another machine for producing a fibrous web or an upstream process for treating a fibrous suspension.
Roll stand with axially displaceable work rolls with a media feed, comprising a media coupling able to accompany an axial work roll displacement, wherein the media coupling comprises at least one first coupling member, which is complementary in configuration to a second coupling member at a work roll chock and can be brought into and out of engagement therewith, for at least one feed line, wherein the media coupling comprises at least one coupling mount at least for the first coupling member and the coupling mount is axially adjustable in correspondence with the displacement travel of the work rolls, characterised in that at least one rotary drive, which produces a translational movement of the coupling mount, for the adjustment of the coupling mount is provided.
An apparatus comprising: - a multi-part housing, - an electric circuitry arranged within the housing, - connection devices (10, 11) for connecting the electric circuitry to two lines (4, 5) carrying a current of a solar module and being provided with insulations, - such that at least one component of the electric circuitry is connected in parallel to the solar module, - wherein parts (21, 22) of the housing are capable to be assembled around the lines running with their insulations through the housing, and - wherein the connection devices (10, 11) include insulation displacement terminals (9, 27) configured to displace the insulations and electrically contact the two lines (4, 5) while assembling the housing, characterised in that - for at least one of the lines (4, 5), a cutting blade made of an electrically insulating material is provided, configured to cut through the at least one of the lines (4, 5) while assembling the housing, wherein on both sides of the cutting blade insulation displacement terminals (9, 27) are arranged. - a multi-part housing, - an electric circuitry arranged within the housing, - connection devices (10, 11) for connecting the electric circuitry to two lines (4, 5) carrying a current of a solar module and being provided with insulations, - such that at least one component of the electric circuitry is connected in parallel to the solar module, - wherein parts (21, 22) of the housing are capable to be assembled around the lines running with their insulations through the housing, and - wherein the connection devices (10, 11) include insulation displacement terminals (9, 27) configured to displace the insulations and electrically contact the two lines (4, 5) while assembling the housing, - for at least one of the lines (4, 5), a cutting blade made of an electrically insulating material is provided, configured to cut through the at least one of the lines (4, 5) while assembling the housing, wherein on both sides of the cutting blade insulation displacement terminals (9, 27) are arranged.
A method for performing an in situ proximity assay, comprising: (a) labeling a biological sample with a plurality of conjugates that each comprise: i. a binding agent that binds to a site or sequence in the sample and ii. a first oligonucleotide; (b) ligating pairs of first oligonucleotides together, in situ, in the presence of a splint oligonucleotide to produce a first product, wherein the ligation is splinted by the splint oligonucleotide; (c) ligating the ends of the splint oligonucleotide to a first reporter oligonucleotide and a second reporter oligonucleotide, in situ, to produce a reporter probe, wherein: i. the ligation is splinted by the first product, ii. the first reporter oligonucleotide has a 5' end that is exonuclease resistant and a 3' hydroxyl; iii. the second reporter oligonucleotide has a 3' end that is exonuclease resistant and a 5' phosphate; and iv. the reporter probe is exonuclease resistant; and (d) treating the sample with an exonuclease to remove unligated reporter oligonucleotides, splint oligonucleotide, and first oligonucleotide. (a) labeling a biological sample with a plurality of conjugates that each comprise: i. a binding agent that binds to a site or sequence in the sample and ii. a first oligonucleotide; (b) ligating pairs of first oligonucleotides together, in situ, in the presence of a splint oligonucleotide to produce a first product, wherein the ligation is splinted by the splint oligonucleotide; (c) ligating the ends of the splint oligonucleotide to a first reporter oligonucleotide and a second reporter oligonucleotide, in situ, to produce a reporter probe, wherein: i. the ligation is splinted by the first product, ii. the first reporter oligonucleotide has a 5' end that is exonuclease resistant and a 3' hydroxyl; iii. the second reporter oligonucleotide has a 3' end that is exonuclease resistant and a 5' phosphate; and iv. the reporter probe is exonuclease resistant; and i. the ligation is splinted by the first product, ii. the first reporter oligonucleotide has a 5' end that is exonuclease resistant and a 3' hydroxyl; iii. the second reporter oligonucleotide has a 3' end that is exonuclease resistant and a 5' phosphate; and iv. the reporter probe is exonuclease resistant; and (d) treating the sample with an exonuclease to remove unligated reporter oligonucleotides, splint oligonucleotide, and first oligonucleotide.
A compound of Formula I: or a pharmaceutically acceptable salt or solvate thereof, wherein: n is an integer from 1 to 8; X is O or S; Y is O or S; and each of R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9, R 10 and R 11 are independently selected from hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heterocycloalkyl, substituted heterocycloalkyl, heteroaryl, substituted heteroaryl, hydroxyl, alkoxyl, substituted alkoxyl, substituted acyloxy, alkoxycarbonyl, substituted alkoxycarbonyl, thiol, acyl, amino, substituted amino, aminoacyl, acylamino, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, -COR 12, -C OR 12, -C NR 12 R 13, -C=NR 12, - OR 12, -OC R 12, -S t -R 7, -NR 12 R 13, -NR 12 C R 13, -N=CR 12 R 13, wherein t is 0, 1, 2 or 3 and R 12 and R 13 are independently selected from hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryloxy or halogen for use in a method of treating cardiac valve disease by administering to a subject in need thereof a therapeutically effective amount of said compound. n is an integer from 1 to 8; X is O or S; Y is O or S; and each of R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9, R 10 and R 11 are independently selected from hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heterocycloalkyl, substituted heterocycloalkyl, heteroaryl, substituted heteroaryl, hydroxyl, alkoxyl, substituted alkoxyl, substituted acyloxy, alkoxycarbonyl, substituted alkoxycarbonyl, thiol, acyl, amino, substituted amino, aminoacyl, acylamino, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, -COR 12, -C OR 12, -C NR 12 R 13, -C=NR 12, - OR 12, -OC R 12, -S t -R 7, -NR 12 R 13, -NR 12 C R 13, -N=CR 12 R 13, wherein t is 0, 1, 2 or 3 and R 12 and R 13 are independently selected from hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryloxy or halogen for use in a method of treating cardiac valve disease by administering to a subject in need thereof a therapeutically effective amount of said compound.
A system comprising: a control node; and an exposure function entity between the control node and an Application Server; wherein if the control node has received a NAS (Non Access Stratum) message with non-IP data from a terminal and has sent a Request message for NIDD (Non-IP Data Delivery) including the non-IP data to the exposure function entity during Mobile Originated procedure for NIDD, the control node is configured to: clear a Not Reachable for NIDD flag for the terminal, and skip sending an Indication message for NIDD to the exposure function entity, and the exposure function entity is configured to: send a Request message for NIDD including downlink non-IP data buffered in the exposure function entity toward the control node if the exposure function entity has not received the Indication message for NIDD from the control node. a control node; and an exposure function entity between the control node and an Application Server; wherein if the control node has received a NAS (Non Access Stratum) message with non-IP data from a terminal and has sent a Request message for NIDD (Non-IP Data Delivery) including the non-IP data to the exposure function entity during Mobile Originated procedure for NIDD, the control node is configured to: clear a Not Reachable for NIDD flag for the terminal, and skip sending an Indication message for NIDD to the exposure function entity, and the exposure function entity is configured to: send a Request message for NIDD including downlink non-IP data buffered in the exposure function entity toward the control node if the exposure function entity has not received the Indication message for NIDD from the control node. the control node is configured to: clear a Not Reachable for NIDD flag for the terminal, and skip sending an Indication message for NIDD to the exposure function entity, and clear a Not Reachable for NIDD flag for the terminal, and skip sending an Indication message for NIDD to the exposure function entity, and the exposure function entity is configured to: send a Request message for NIDD including downlink non-IP data buffered in the exposure function entity toward the control node if the exposure function entity has not received the Indication message for NIDD from the control node.
A system, comprising: a plurality of ride vehicle modules (12, 14, 16, 18), wherein each of the plurality of ride vehicle modules (12, 14, 16, 18) comprises: an interlock system (70; 80; 94; 100; 110) configured to perform linking operations to join to other ride vehicle modules (12, 14, 16, 18) to form a cluster and delinking operations to separate from the other ride vehicle modules (12, 14, 16, 18) throughout a ride; control circuitry configured to control the interlock system (70; 80; 94; 100; 110) and movement of the respective ride vehicle module (12, 14, 16, 18) independently or as a part of the cluster; and communication circuitry configured to wirelessly communicate with the other ride vehicle modules (12, 14, 16, 18) internal and/or external to the cluster; and wherein the cluster is configured to change sizes throughout the ride by performing linking and delinking operations as desired via the control circuitry of each of the plurality of ride vehicle modules (12, 14, 16, 18) controlling its interlock system (70; 80; 94; 100; 110) and via the communication circuitry coordinating the operations between the plurality of ride vehicle modules (12, 14, 16, 18). a plurality of ride vehicle modules (12, 14, 16, 18), wherein each of the plurality of ride vehicle modules (12, 14, 16, 18) comprises: an interlock system (70; 80; 94; 100; 110) configured to perform linking operations to join to other ride vehicle modules (12, 14, 16, 18) to form a cluster and delinking operations to separate from the other ride vehicle modules (12, 14, 16, 18) throughout a ride; control circuitry configured to control the interlock system (70; 80; 94; 100; 110) and movement of the respective ride vehicle module (12, 14, 16, 18) independently or as a part of the cluster; and communication circuitry configured to wirelessly communicate with the other ride vehicle modules (12, 14, 16, 18) internal and/or external to the cluster; and an interlock system (70; 80; 94; 100; 110) configured to perform linking operations to join to other ride vehicle modules (12, 14, 16, 18) to form a cluster and delinking operations to separate from the other ride vehicle modules (12, 14, 16, 18) throughout a ride; control circuitry configured to control the interlock system (70; 80; 94; 100; 110) and movement of the respective ride vehicle module (12, 14, 16, 18) independently or as a part of the cluster; and communication circuitry configured to wirelessly communicate with the other ride vehicle modules (12, 14, 16, 18) internal and/or external to the cluster; and wherein the cluster is configured to change sizes throughout the ride by performing linking and delinking operations as desired via the control circuitry of each of the plurality of ride vehicle modules (12, 14, 16, 18) controlling its interlock system (70; 80; 94; 100; 110) and via the communication circuitry coordinating the operations between the plurality of ride vehicle modules (12, 14, 16, 18).